A new international clinical trial led by the National Cancer Center Singapore is reporting that three years of aspirin ...
Scientists have made 'exciting,' patient-friendly advances in developing a non-toxic bacterial therapy, BacID, to deliver cancer-fighting drugs directly into tumors. This emerging technology holds ...
Gadoquatrane, a contrast agent Bayer is developing for use in MRI scans, like those done in MS, uses 60% less gadolinium and ...
Treating patients with aspirin after completion of standard adjuvant therapy for colorectal cancer failed to significantly ...